论文部分内容阅读
目的分析探讨胺碘酮治疗老年室性心律失常患者的临床疗效。方法选择年龄≥65岁的室性心律失常患者60例随机分为观察组和对照组各30例,两组患者在试验前10d均停用其他抗心律失常药物。对照组患者给予内科综合治疗,观察组在对照组治疗基础上应用胺碘酮,两组患者均治疗4周。观察记录两组患者的临床疗效及不良反应发生情况。结果观察组的显效率、总有效率分别为56.67%、93.34%,对照组的显效率、总有效率分别为40.00%、83.33%,两组比较差异有统计学意义(P<0.05);两组不良反应发生率无显著差异(P>0.05)。结论胺碘酮在治疗老年室性心律失常的临床过程中,其疗效确切,效果显著,且副反应小,是老年室性心律失常患者最为理想的治疗药物之一。
Objective To investigate the clinical efficacy of amiodarone in the treatment of elderly patients with ventricular arrhythmia. Methods Sixty patients with ventricular arrhythmias aged ≥ 65 years were randomly divided into observation group (30 cases) and control group (30 cases). All the patients in the two groups discontinued other antiarrhythmic drugs 10 days before the experiment. Patients in the control group were given comprehensive medical treatment. The observation group was treated with amiodarone on the basis of the control group, and both groups were treated for 4 weeks. Observe and record the clinical curative effect and adverse reaction of two groups of patients. Results The effective rate and total effective rate in the observation group were 56.67% and 93.34% respectively. The effective rate and total effective rate in the control group were 40.00% and 83.33% respectively. There was significant difference between the two groups (P <0.05) No significant difference in the incidence of adverse reactions (P> 0.05). Conclusion Amiodarone is one of the most ideal therapeutic drugs for senile ventricular arrhythmias in clinical treatment of senile ventricular arrhythmias.